Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression-Reference-Cited by-同舟云学术

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression

Published:2015-09-21 Issue:32 Volume:6 Page:32761-32773
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Wu Mingsong¹,Si Shuhui²,Li Yan³,Schoen Susan²,Xiao Guang-Qian⁴,Li Xueying¹,Teh Bin Tean⁵,Wu Guan¹⁴,Chen Jindong¹²

Affiliation:

1. Department of Cell Biology and Genetics, Zunyi Medical University, Zunyi 563099, China

2. Kidney Cancer Research Laboratory, Department of Urology, University of Rochester Medical Center, Rochester, NY 14642, USA

3. State Key Laboratory of Bioactive Substances and Functions of Nature Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China

4. Department of Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA

5. NCCS-VARI Translational Cancer Research Laboratory, National Cancer Centre, 169610, Singapore

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel variant in the FLCN gene in a Chinese family with Birt–Hogg–Dubé syndrome;Molecular Genetics & Genomic Medicine;2024-07

2. Genetically modified organisms in urological cancer;Genetically Modified Organisms [Working Title];2024-05-22

3. Metabolic alterations in hereditary and sporadic renal cell carcinoma;Nature Reviews Nephrology;2024-01-22

4. Surgical Management of Hereditary Kidney Cancer Syndromes;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

5. The mTOR Pathway in Pluripotent Stem Cells: Lessons for Understanding Cancer Cell Dormancy;Membranes;2021-11-07